Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 5/2009

01-05-2009 | Meeting Report

Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany

Authors: Marij J. P. Welters, Nadine van Montfoort, Selina Khan, Ralf G. Meyer, Cedrik M. Britten

Published in: Cancer Immunology, Immunotherapy | Issue 5/2009

Login to get access

Excerpt

After one visit to Würzburg in 2007 the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT) was organized again in Mainz on May 15 and 16, 2008. More than 350 participants attended the scientific sessions with program topics ranging from fundamental research on antigen processing and mechanisms of breaking tolerance to more translational studies on adoptive T-cell transfer, vaccination and the use of adjuvants or immunomodulating agents. In addition, an extra session was organized which focused on the monitoring of immunotherapy-induced immune responses. Selected posters were discussed in short presentations during three parallel sessions. This year’s meeting provided the attendees with a comprehensive overview of the most prominent work in the field. It proved to be a very interesting and stimulating meeting, with plenty of opportunity to “meet the expert”. In contrast to prior CIMT meetings, in which the great majority of participants came from Germany, this year’s meeting attracted a much more international audience, reflecting the increasing interest in this meeting platform in- and out-side of Europe. …
Metadata
Title
Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany
Authors
Marij J. P. Welters
Nadine van Montfoort
Selina Khan
Ralf G. Meyer
Cedrik M. Britten
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 5/2009
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-008-0614-2

Other articles of this Issue 5/2009

Cancer Immunology, Immunotherapy 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine